China Aspirin Enteric-Coated Tablets Acetylsalicyic Acid with GMP, Find details about China GMP, Medicine from Aspirin Enteric-Coated Tablets Acetylsalicyic Acid with GMP
[Indications] Inhibitory effect of aspirin on platelet aggregation. Therefore, indications for enteric-coated aspirin tablets are as follows:
Reduce the risk of acute myocardial infarction in suspected patients;
Prevent the recurrence of myocardial infarction;
Secondary prevention of stroke;
Reduce the risk of transient ischemic attack (TIA) and subsequent stroke;
Reduce the risk of patients with stable and unstable angina;
After arterial surgery or interventional procedures, such as percutaneous coronary angioplasty (PTCA), coronary artery bypass (CABG), carotid endarterectomy, arteriovenous shunt;
To prevent deep vein thrombosis and pulmonary embolism after major surgery;
Reduces the risk of myocardial infarction in people with cardiovascular risk factors (family history of coronary heart disease, diabetes, dyslipidemia, hypertension, obesity, smoking history, age older than 50 years).
Main ingredient | Aspirin. |
specification | 100mg |
Packaging | Aluminum plastic packaging, 100 pieces/box |
Storage | Sealed and stored below 25ºC. |
Validity | 60 months |